These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 21154343)

  • 41. Prophylactic nasal continuous positive airways pressure for preventing morbidity and mortality in very preterm infants.
    Subramaniam P; Henderson-Smart DJ; Davis PG
    Cochrane Database Syst Rev; 2005 Jul; (3):CD001243. PubMed ID: 16034858
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Post-extubation prophylactic nasal continuous positive airway pressure in preterm infants: systematic review and meta-analysis.
    Davis P; Henderson-Smart D
    J Paediatr Child Health; 1999 Aug; 35(4):367-71. PubMed ID: 10457294
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Continuous distending pressure for respiratory distress syndrome in preterm infants.
    Ho JJ; Subramaniam P; Henderson-Smart DJ; Davis PG
    Cochrane Database Syst Rev; 2002; (2):CD002271. PubMed ID: 12076445
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Extubation from low-rate intermittent positive airways pressure versus extubation after a trial of endotracheal continuous positive airways pressure in intubated preterm infants.
    Davis PG; Henderson-Smart DJ
    Cochrane Database Syst Rev; 2000; 2001(2):CD001078. PubMed ID: 10796244
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Elective high-frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants.
    Neonatology; 2013; 103(1):7-8; discussion 8-9. PubMed ID: 23037971
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Continuous distending airway pressure for respiratory distress syndrome in preterm infants.
    Ho JJ; Subramaniam P; Henderson-Smart DJ; Davis PG
    Cochrane Database Syst Rev; 2000; (3):CD002271. PubMed ID: 10908543
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Continuous distending pressure for respiratory distress syndrome in preterm infants.
    Ho JJ; Subramaniam P; Henderson-Smart DJ; Davis PG
    Cochrane Database Syst Rev; 2000; (4):CD002271. PubMed ID: 11034747
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Body positioning for spontaneously breathing preterm infants with apnoea.
    Ballout RA; Foster JP; Kahale LA; Badr L
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004951. PubMed ID: 28067942
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prophylactic nasal continuous positive airways pressure for preventing morbidity and mortality in very preterm infants.
    Subramaniam P; Henderson-Smart DJ; Davis PG
    Cochrane Database Syst Rev; 2000; (2):CD001243. PubMed ID: 10796424
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Controversies surrounding xanthine therapy.
    Millar D; Schmidt B
    Semin Neonatol; 2004 Jun; 9(3):239-44. PubMed ID: 15050217
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early versus late discontinuation of oxygen in preterm or low birth weight infants.
    Askie LM; Henderson-Smart DJ
    Cochrane Database Syst Rev; 2001; (4):CD001076. PubMed ID: 11687095
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Supplemental oxygen for the treatment of prethreshold retinopathy of prematurity.
    Lloyd J; Askie L; Smith J; Tarnow-Mordi W
    Cochrane Database Syst Rev; 2003; 2003(2):CD003482. PubMed ID: 12804470
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Devices and pressure sources for administration of nasal continuous positive airway pressure (NCPAP) in preterm neonates.
    De Paoli AG; Davis PG; Faber B; Morley CJ
    Cochrane Database Syst Rev; 2002; (4):CD002977. PubMed ID: 12519580
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.
    Stevens TP; Blennow M; Soll RF
    Cochrane Database Syst Rev; 2002; (2):CD003063. PubMed ID: 12076469
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of methylxanthine therapies for the treatment and prevention of apnea of prematurity.
    Schoen K; Yu T; Stockmann C; Spigarelli MG; Sherwin CM
    Paediatr Drugs; 2014 Apr; 16(2):169-77. PubMed ID: 24399614
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Caffeine citrate: a review of its use in apnoea of prematurity.
    Comer AM; Perry CM; Figgitt DP
    Paediatr Drugs; 2001; 3(1):61-79. PubMed ID: 11220405
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prolonged versus short course of indomethacin for the treatment of patent ductus arteriosus in preterm infants.
    Herrera C; Holberton J; Davis P
    Cochrane Database Syst Rev; 2004; (1):CD003480. PubMed ID: 14974018
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Walia R; Shah S
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003481. PubMed ID: 18254020
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vitamin A supplementation to prevent mortality and short and long-term morbidity in very low birthweight infants.
    Darlow BA; Graham PJ
    Cochrane Database Syst Rev; 2007 Oct; (4):CD000501. PubMed ID: 17943744
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Late (>7 days) postnatal corticosteroids for chronic lung disease in preterm infants.
    Halliday HL; Ehrenkranz RA; Doyle LW
    Cochrane Database Syst Rev; 2009 Jan; (1):CD001145. PubMed ID: 19160189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.